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1. Introduction 
Activation of the classical pathway of the comple- 
ment system occurs upon binding of the first compo- 
nent of complement Cl, to antibody--antigen com- 
plexes [I]. Cl is a complex Clq(Clr)~(Cls)* of the 
binding protein Cl q, and the zymogens Cl r and Cl s 
[2]. IgG protomers in immune complexes, in heat 
aggregated IgG [3] and in defined IgG-oligomers [4] 
bind to the heads of Clq [5] probably via their CR2 
domains [C;], The zymogens are sequentially converted 
to proteases during activation [7]. 
Two Inechanisms have been proposed for CI Fixa- 
tion and activation by IgG upon antigen binding [8,9]. 
According to the allosteric model, the binding of 
antigen to the variable domain triggers a conforma- 
tional change in the Fc portion of the immuno- 
globulin which leads to enhanced binding. The alter- 
native association model suggests that polyvalent anti- 
gens may function by aggregating antibodies to large 
complexes which exhibit an enhanced binding affinity 
to the multivalent Cl q by virtue of multiple binding 
interactions. Recent experiments lent support to the 
latter model. Chemically crosslinked antibodies [lo] 
showed an increasing binding constant in the order 
dimer < trimer < tetramer [4]. This interaction was 
not influenced by the binding of a monovalent non- 
asaccharide antigen [S]. 
Binding and activation of Cl are two distinct pro- 
cesses. Tryptophan modification drastically reduced 
IgG anticomplementary activity but did not signifi- 
cantly alter affinity of IgG to Clq [ 111. It was also 
found that Cl s can be activated by molecules which 
did not bind to Clq [K?]. We therefore studied the 
A bbreviutions: DFP, diiso~ropyl~uorophosphate 
1.52 
activation process by IgG-oligomers in the presence 
and absence of a specific nonasaccharide ailtigen and 
we compared results to data obtained with our binding 
studies [4] carried out with the same material. 
2. Materials and methods 
Cl q was prepared according to [ 131 and unacti- 
vated C 1 r and C 1 s according to [4] from fresh human 
blood plasma (Blutspendezentrum Basel). DFP was 
added to the clotted plasma and at various steps 
during the prepar-ation. Purified Clr and Cls was 
extensively dialysed against 5 mM DFP in 10 mM Tris 
(hydroxymethyl) aminomethane (pH 7.4) containing 
150 mM NaCl (buffer A). Rabbit IgG against SII 
pneumococcal polysaccharide [ 151 IgG dimers [lo] 
and SII nonasaccharide [151 were prepared as 
described. Radiodination of Cl s was performed 
according to [ 161 with Na ‘*‘I (EIR, W~renlingen) 
and lactoperoxidase (Sigma). The iodinated protein 
was stored at - -70°C in buffer A and was used within 
a month. 
2.2. C1 activation test 
A modification of the Cl activation test in [ 171 
was used. Cl was first reconstituted from C 1 q, Cl r 
and “251-labelled Cls present in a 1:2:2 molar ratio 
in buffer A containing 5 mM Ca’+ at 20°C for 20 min. 
Their concentrations were determined by quantitative 
amino acid analysis. The reconstituted Cl (60 nM) 
was incubated at 30°C with different concentrations 
of oligomers in the absence or presence of SII nona- 
saccharide (2 X 10”’ M). After 20 min, activation 
was stopped by the addition of an equal volume of 
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0.2 M Tris (hydroxym~thyl) aminomethane containing 
7% SDS, 25% 2-thioglycerine and 0.01 M bromphenol 
blue R-250, and by heating to 5O*C. Samples (30 ~1) 
were reduced and denatured by boiling for 10 nun 
and loaded on 8Yo SDSpolyacrylamide gels. The gels 
were fixed with 5% trichloroacetic acid in water- 
methanol 1: 1 (v/v), dried and exposed to Kodak X-ray 
films (Kodirex). Two controls were included : a blank 
without IgG (no activation) and a 100% control in 
which Cl was incubated with a mixture of (IgC), and 
(IgG), (4 PM) (full activation). The autoradiographic 
pattern was scanned in a Beckman Acta V spectro- 
photometer equipped with a gel scanner and band 
intensities were quantitated by means of a Hewlett 
Packard integrator model 3385 A. To correct for 
pipetting errors, the band intensity was normalized 
by the total intensity of all bands per slot. The activa- 
tion was followed by the disappearance of the band 
of unsplit Cls (app. mol. wt 85 000) and the appear- 
ance of the larger splitting product of activated Cl-s’ 
(app. mol. wt 59 000) [ 171. The extent of activation 
Ag was calculated from the normalized band intensity 
(I) of the ClS a-chain, the intensity of the blank (1J 
and the 100% control (Z,) according to the relation: 
I-I, 
AS: (20 min) = - 
1, -I, 
Ideally, I0 should be zero, a value which was not 
achieved due to the presence of lo-30% split but 
DFP inactivated Cl s in our preparation. 
3. Results and discussion 
3.1, Activation of Cl by IgG and IgG-oligomers 
The rate of Cl activation at 30°C was measured 
over a wide range of IgG and IgG-oligomer concentra- 
tion (fig.1). The extent of activation AT (20 min) was 
plotted versus the total concentration of IgG proto- 
mers. Thus, activation differences between the various 
oligomers can be directly related to the poiymeriza- 
tion state of IgG molecules. 
The efficiency of activation increases with increas- 
ing size of the IgG oligomers. The concentration 
dependence of the rate of activation follows approxi- 
mately the concentration dependence established for 
the binding of IgG [18] and IgG oligomers [4]. This 
is delnonstrated in fig.2, in which the concentration 
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Fig.1. Concentration dependence of the extent of activation 
of Cl s for 20 min (A _ (20 min)) in the presence and absence 
of the monovalent noiasaccharide antigen. Cl reconstituted 
from Clq, Clr and ‘2sI-labelled Cl s was incubated with 
IgG monomers, dimers and trimers in 10 mM Tris (hydroxy- 
methyl) amino methane buffer (pH 7.4) containing 0.15 M 
NaCl and 5 mM CaCl, at 30°C (open symbols). When nona- 
saccharide was added to dimers and monomers it was 0.2 mM 
(filled symbols). This corresponds to a degree of saturation 
of the antigen binding sites of >98%, according to Kb = 
3 X IO5 M-’ [23]. 
of fgG protol?lers at which half of the Cls is activated 
in 20 min is plotted versus the concentration at which 
half-saturation was observed in binding experiments 
(4,181. The IWO concentrations are approximately 
equal which indicates that the rate of activation is 
approximately proportional to the degree of satura- 
11 
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Fig.2. Correlation between binding and activation. The total 
concentration of IgG protomers at which half of the Cls is 
activated (data drawn from fig.1) is plotted against he 
concentration of half-saturation. The latter was determined 
from ultracentrifugation [5,18] (0) or by complement 
fixation [4] (0). Error bars indicate lower and upper limits 
of data from different experiments. 
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tion of Cl by IgG or IgG oligomers. Experiments in 
which initial rates of activation are compared with 
degrees of saturation are in progress in order to reveal 
more detailsof the dependence of activation on satura- 
tion. The present data clearly demonstrate that no 
minimum size of IgG clusters is needed for activation, 
i.e., the binding of Cl to IgG appears to be sufficient 
for activation regardless of whether IgG monomers or 
polymers are employed. Solely the overalf binding 
constant and therefore the concentration at which 
activation takes place are influenced by the size of 
the IgG oligomers. 
The observed correlation between binding and 
activation may be explained by an activation mecha- 
nism in which the binding of Clq to IgC or IgG-oligo- 
mer constitutes a fast pre-equilibrium of the sequential 
activation of CIr and Cls in IgG-liganded Cl. First, 
Clr is split without the action of another enzyme but 
in the presence of IgG [4,7]. A similarity between this 
process and the activation of plasnlinoger~ by the 
streptokinase plasmin complex may exist 1191. Most 
likely Cl r (and perhaps Ci s) are activated by a direct 
contact with some region in the IgG protomers medi- 
ated by the binding protein Cl q. An example in which 
a binding process is sufficient for activation was eluci- 
dated in molecular detail [N]: The active site of 
trysinogen may be liberated by a binding of the dipep- 
tide Ilu-Val. 
3.2. Antigen independence of activation 
The activation process (fig.1 ) and the binding affin- 
ities [4] are ~dependent of the saturation of the 
antigen binding site by a specific monovalent nona- 
saccharide antigen. This is at variance with a postulated 
allosteric mechanism of antigen action. Antigen-depen- 
dent conformation changes were demonstrated by 
spectroscopic [21] and kinetic studies [22] but the 
present data indicate that they have no effect on CI 
activation. The conversions of Cl r and Cl s to their 
activated species are initiated by the saturation of Cl 
by IgG protomers and no antigen is needed for these 
processes to take place. The role of multivalent antigens 
appears to be the formation of IgG clusters which can 
bind sufficiently strongly to Cl in order to provide 
the necessary saturation with IgG protomers. 
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